Business Account Executive - Chicago

Business Account Executive - Chicago

We are looking for an experienced and talented Business Account Executive (BAE) to commercially represent GIVLAARI® and OXLUMO® in the United States and have a significant impact on the lives of AHP patients. AHP's represent a sub-group of Porphyrias, characterized by the occurrence of neuro-visceral attacks with or without cutaneous manifestations. PH1 is a rare, life-threatening disease that can cause serious damage to kidneys and progressively to other organs.

The BAE will be principally responsible for driving physician and patient identification, disease awareness, overall market development, and brand awareness within their ascribed territory. The BAE will be responsible for achieving territory targets and other business objectives through account and customer strategies, while also partnering & collaborating very closely with internal and external stakeholders to effectively manage all aspects of the regional business.

Key Responsibilities:

• Drive patient identification through appropriate HCP driven strategies including market development, increase brand awareness through building and executing a territory strategy/account plan; continuously assess opportunities within markets and accounts to launch successfully.
• Effectively prioritize and manage time, activities, and resources in order to optimize access to academic and community HCPs.
• Build and maintain relationships with HCPs and office staff by maximizing their time through planning, leveraging insights, and conducting post-call analysis refining tactics based on opportunities.
• Proactively build effective working relationships with internal/external stakeholders; drive agreement/decisions from multiple stakeholders; demonstrated high level of emotional intelligence adapting communication based on different stakeholders.
• Collaborate with stakeholders across all commercial departments including; patient services, field reimbursement, and others to ensure access at site of care and that logistics are in place to administer medications.
• Collaborate with key accounts and physicians to build individual account plans to drive patient identification through market development and physician education; achieve sales goals, and maintain relationships in order to maximize sales results.
• Execute speaker programs, local sponsor ships, displays and exhibits, both in and out of office across multiple account types: academic institutions, physician offices, infusion centers, and alternate site locations.
• Routinely report territory-level market dynamics and trends, including prescriber opinion and competitive activity to RBD as required.

Qualifications:

• Bachelor's degree required 5+ years of demonstrated success in biotech, specialty pharmaceuticals, or medical devices.
• Experience, success and relationships in Rare Disease, Gastroenterology, Hepatology, Neurology, Hematology/Oncology, pediatric and adult Nephrology and/or Urology are preferred but not required.
• Buy & Bill understanding and experience working with HUB patient services preferred but not required.
• Thorough understanding of site of care identification, development and education.
• Strong examples of applied entrepreneurial mindset, business analytics and data analysis required.
• Experience supporting biologic therapy administered by designated HCPs preferred.
• Experience driving, leading and delivering upon territory-level cross functional business planning.
• Must be familiar with relevant legal and regulatory environment in biotech/pharmaceutical industry.
• Strong communication and listening skills. Effective at managing complex individualized cases in a compliant manner.
• Overnight travel required including travel to Boston, congresses and large geographical territories
• Candidates must have a valid driver's license. Must live in the assigned territory.

U.S. Pay Range $ - $

About Alnylam:
We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning…